Biofrontera Inc. (BFRI)
NASDAQ: BFRI
· Real-Time Price · USD
0.66
0.00 (0.15%)
At close: Jun 16, 2025, 3:59 PM
0.70
5.79%
After-hours: Jun 16, 2025, 06:31 PM EDT
0.15% (1D)
| Bid | 0.6 |
| Market Cap | 6.23M |
| Revenue (ttm) | 37.99M |
| Net Income (ttm) | -11.53M |
| EPS (ttm) | -0.83 |
| PE Ratio (ttm) | -0.8 |
| Forward PE | -1.1 |
| Analyst | Buy |
| Ask | 0.7 |
| Volume | 85,083 |
| Avg. Volume (20D) | 157,514 |
| Open | 0.63 |
| Previous Close | 0.66 |
| Day's Range | 0.63 - 0.69 |
| 52-Week Range | 0.54 - 2.22 |
| Beta | 0.30 |
About BFRI
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol BFRI
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for BFRI stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock Forecasts2 months ago
-16.5%
Biofrontera shares are trading lower after the com...
Unlock content with
Pro Subscription
5 months ago
+6.31%
Biofrontera shares are trading higher after the company announced the last patient completed the 1 year follow-up of study ALA-BCC-CT013 in December 2024.
1 month ago · accessnewswire.com
Biofrontera Inc. to Report First Quarter FY 2025 Financial Results on May 15, 2025WOBURN, MA / ACCESS Newswire / May 6, 2025 / Biofrontera Inc. (Nasdaq:BFRI) ("Biofrontera" or the "Company"), a biopharmaceutical company specializing in the commercialization of dermatological produc...
